Cerebral Tissue Oxygenation Values in Newborns Measured Using Laser and LED NIRS Oximeters
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01496027
: December 21, 2011
Last Update Posted
: September 10, 2013
Poznan University of Medical Sciences
Information provided by (Responsible Party):
Tomasz Szczapa, Poznan University of Medical Sciences
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
up to 1 Day (Child)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Clinically stable, spontaneously breathing newborns will be included in the study. Enrolled patients will be divided into two groups: 15 term (≥37 weeks GA) and 15 preterm (32-37 weeks GA) newborns. NIRS measurements will be performed on the 1st and 3rd day of life.
Spontaneously breathing newborns
Congenital heart defects or anomalies of central nervous system
MacLeod D; Ikeda K; Vacchiano C Simultaneous Comparison of FORE-SIGHT and INVOS Cerebral Oximeters to Jugular Bulb and Arterial Co-Oximetry Measurements in Healthy Volunteers ANESTH ANALG 2009; 108(SCA Suppl);1-104
Tomasz Szczapa, M.D., Poznan University of Medical Sciences